Cardiac development results from a variety of regulatory processes. The HCCB Research Ctr is focused on defining one of these processes-the transcriptional regulatory network. Regulation of RNA transcription is recognized to play critical roles in developmental processes, definition of the entire repertoire of transcriptional regulators and their interactions during cardiac embryogenesis remains largely unknown. While large numbers of transcription factors have been identified that are involved in cardiac development the processes that activate these transcription factors and the downstream targets of these transcription factors are not known. We propose to employ novel genomic and genetic methods to define the network of transcription factors that regulate multiple steps in cardiac development and overlay that network on the RNA expression profile found in these developing tissues. In the end this should provide an RNA blueprint for understanding cardiac development. Definition of the network required for cardiac development would enhance understandings of the roles of recently discovered post-transcriptional regulatory mechanisms (e.g. microRNAs) that may modify developmental processes. We will take advantage of novel technologies to define the RNA expression networks, including both temporal and spatial patterns of gene expression that formation of primary and secondary heart fields to adult chamber formation. Three different novel technologies will be employed to define RNA profiles in each tissue at critical stages of development (DSAGE and RNAseq) and to identify likely downstream targets of particular transcription factors (bioCHIP). DSAGE and RNAseq employ high throughput DNA sequencing technologies to define the structure and level of RNA expression, while bioCHIP defines the promoter sites within the genome that are bound by particular transcription factors. Together this information will define transcription factor levels and their downstream target genes. Molecules that are identified as central for developmental steps will be validated by perturbation experiments, including molecular and phenotypic analyses. Together with data from human studies, we will construct a cardiac developmental blueprint and interrogate how perturbations of this blueprint result in congenital heart disease. 1) Define the transcriptome in the primary heart field, the secondary heart field and in developing cardiac chambers using DSAGE and RNAseq. 2) Identify binding targets of GATA4, F0G2, TBX5, NKX2.5 and other transcription factors critical for cardiac development using DCHIP. 3) Construct a developmental blueprint for developmental stages of cardiac specification and morphogenesis from .model organism and human datasets. 4) Validate crifical role of defines nodes in the blueprint by perturbing RNA levels and defining molecular and phenotypic consequences.

Public Health Relevance

The goal of the proposed research is to define transcriptional networks that lead to formation of the mature heart. Defining this network will provide novel insights into the pathogenesis of a variety of congenital heart diseases (CHD). Eventually such studies may allow new therapeutic approaches to CHD.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01HL098166-04S1
Application #
8663738
Study Section
Special Emphasis Panel (ZHL1-CSR-B (S1))
Program Officer
Schramm, Charlene A
Project Start
2009-09-30
Project End
2015-07-31
Budget Start
2013-06-01
Budget End
2013-07-31
Support Year
4
Fiscal Year
2013
Total Cost
$15,796
Indirect Cost
$6,463
Name
Harvard University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Lin, Zhiqiang; Zhou, Pingzhu; von Gise, Alexander et al. (2015) Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res 116:35-45
Zhang, Jun; Sawyer, Janet K; Marshall, Stephanie M et al. (2014) Cholesterol esters (CE) derived from hepatic sterol O-acyltransferase 2 (SOAT2) are associated with more atherosclerosis than CE from intestinal SOAT2. Circ Res 115:826-33
Diman, Nata Y S-G; Brooks, Gabriel; Kruithof, Boudewijn P T et al. (2014) Tbx5 is required for avian and Mammalian epicardial formation and coronary vasculogenesis. Circ Res 115:834-44
Fahed, Akl C; McDonough, Barbara; Gouvion, Cynthia M et al. (2014) UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration. Ann Neurol 75:793-8
Ito, Kaoru; Bick, Alexander G; Flannick, Jason et al. (2014) Increased burden of cardiovascular disease in carriers of APOL1 genetic variants. Circ Res 114:845-50
Li, Kai; Wang, Gang; Andersen, Troels et al. (2014) Optimization of genome engineering approaches with the CRISPR/Cas9 system. PLoS One 9:e105779
Christodoulou, Danos C; Wakimoto, Hiroko; Onoue, Kenji et al. (2014) 5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy. J Clin Invest 124:1364-70
Brown, Juliana R; Zetsche, Bernd; Jackson-Grusby, Laurie (2014) RUSH and CRUSH: a rapid and conditional RNA interference method in mice. Genesis 52:39-48
van den Boogaard, Malou; Smemo, Scott; Burnicka-Turek, Ozanna et al. (2014) A common genetic variant within SCN10A modulates cardiac SCN5A expression. J Clin Invest 124:1844-52
He, Aibin; Gu, Fei; Hu, Yong et al. (2014) Dynamic GATA4 enhancers shape the chromatin landscape central to heart development and disease. Nat Commun 5:4907

Showing the most recent 10 out of 28 publications